Skip to main
FOLD
FOLD logo

Amicus Therapeutics (FOLD) Earnings Dates & Reports

Amicus Therapeutics (FOLD) Most Recent Earnings

Report DateJul 31, 2025
Period EndingQ2 2025
Est. EPS-$0.01
Actual EPS$0.01
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Amicus Therapeutics (FOLD) Earnings per Share (EPS) History

Signup for full access
Browse free

Amicus Therapeutics (FOLD) Latest Earnings

The value each FOLD share was expected to gain vs. the value each share gained.

Amicus Therapeutics (FOLD) reported its most recent earnings on Jul 31, 2025 for Q2 2025, posting earnings per share (EPS) of $0.01. This exceeded analysts' expectations of -$0.01 by 200.00%, marking a Beat.

For comparison, Amicus Therapeutics reported EPS of $0.06 in the same quarter last year.

The company is expected to announce its next earnings report on 11/05/2025, with analysts projecting an EPS of $0.09.

Amicus Therapeutics (FOLD) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 5, 2025
$0.09Next earnings call Nov. 5, 2025
Q2 2025Jul 31, 2025
-$0.01$0.01-200.00%
DeckReportListen
Q1 2025May 1, 2025
$0.08$0.03-62.50%
Q4 2024Feb 19, 2025
$0.09$0.090.00%
Q3 2024Nov 6, 2024
$0.10
View all

Amicus Therapeutics (FOLD) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Amicus Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Jul 31, 2025
May 1, 2025
Feb 19, 2025
Nov 6, 2024

Amicus Therapeutics (FOLD) Earnings FAQs

Amicus Therapeutics (FOLD) last reported earnings on Jul 31, 2025 for Q2 2025, posting an EPS of $0.01, which Beat the estimate of -$0.01 by 200.00%.

For Q2 2025, Amicus Therapeutics (FOLD) reported an EPS of $0.01, exceeding analysts' estimate of -$0.01 by 200.00%.

For Q2 2025, Amicus Therapeutics (FOLD) Beat expectations with an actual EPS of $0.01 vs. an estimated EPS of -$0.01.

Following the last earnings report on Jul 31, 2025, Amicus Therapeutics (FOLD)'s stock price moved — from — to —.

The next Amicus Therapeutics (FOLD) earnings call is scheduled for Nov. 5, 2025, where executives will discuss financial results and outlook.

Amicus Therapeutics (FOLD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.